Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for treating muscle atrophy or sarcopenia including glucagon-like peptide (GLP-1) or GLP-1 receptor agonist

Pharmaceutical composition for treating muscle atrophy or sarcopenia including glucagon-like peptide (GLP-1) or GLP-1 receptor agonist

US Patent 10993993 · Granted May 4, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide compound or pharmaceutically acceptable salt thereof2025
Apparatus for measuring glycation of red blood cells and glycated hemoglobin lev2025
Composition for enhancing exercise performance and fatigue recovery, containing 2025
Composition for enhancing exercise performance and fatigue recovery, containing 2025
Touch display panel2025
4-carbonylamino-4-phenylpyrimidine compound or pharmaceutically acceptable salt 2025
Game2024
Composition for stress relief containing fermented ripened noni and calamansi ex2024
Apparatus for measuring properties of particles in a solution and related method2024
Apparatus for measuring glycation of red blood cells and glycated hemoglobin lev2024
Apparatus for measuring glycation of red blood cells and glycated hemoglobin lev2024
Composition for stress relief containing fermented ripened noni and calamansi ex2024